Johnson & Johnson has received FDA approval to promote Invega Sustenna as a drug that could potentially reduce the risk of incarceration for people with schizophrenia. Read more.
https://www.flmhlaw.com/wp-content/uploads/2018/02/syringe-pills.jpeg24004000Faith Sills, LCSW, CBHCMShttp://www.flmhlaw.com/wp-content/uploads/2017/01/flmhlaw-logo-300x31.pngFaith Sills, LCSW, CBHCMS2018-02-19 11:04:072023-03-08 22:37:24A Drug Company Says This Shot Will Keep You Out of Prison – The Marshall Project
https://www.flmhlaw.com/wp-content/uploads/2018/02/syringe-pills.jpeg
2400
4000
Faith Sills, LCSW, CBHCMS
http://www.flmhlaw.com/wp-content/uploads/2017/01/flmhlaw-logo-300x31.png
Faith Sills, LCSW, CBHCMS2018-02-19 11:04:072023-03-08 22:37:24A Drug Company Says This Shot Will Keep You Out of Prison – The Marshall Project